CVS Health Expands Wegovy Access for Patients Covered Under Its Prescription Drug Plans

CVS Health will broaden patient access to Novo Nordisk’s weight loss medication, Wegovy, for individuals covered under its prescription drug plans. This move aims to make the treatment more readily available to those seeking medical weight management solutions. Specifically, CVS Health plans to enhance the inclusion of Wegovy within its formularies, the lists of drugs covered by its insurance plans. This expanded access is intended to provide a greater number of patients with the opportunity to utilize the medication as part of their weight loss journey, if deemed appropriate by their healthcare provider.

Newsflash | Powered by GeneOnline AI
Date: May 1, 2025

Related posts:

Global Obesity Crisis: 1 in 6 Young People Predicted to Face Obesity by 2050, Study Warns FDA Requires More Extensive Data for Vaccine Approvals, Raising Bar for Manufacturers Pharmacists Discuss Delirium Risk With Anticholinergics for Terminal Secretions in End-of-Life Care TAE Life Sciences and OSUCCC – James Partner to Develop Boron-Based Cancer Therapies

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後